Pro-Neurotensin as a Potential Novel Diagnostic Biomarker for Detection of Nonalcoholic Fatty Liver Disease-Reference-Cited by-同舟云学术

Pro-Neurotensin as a Potential Novel Diagnostic Biomarker for Detection of Nonalcoholic Fatty Liver Disease

Published:2022-06 Issue: Volume:Volume 15 Page:1935-1943
ISSN:1178-7007
Container-title:Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
language:en
Short-container-title:DMSO

Author:

Mohamed Amal A,Abo-Elmatty Dina M,Ezzat Omnia,Mesbah Noha M,Ali Nada S,Abd El Fatah Aliaa Sayed,Alsayed Eman^ORCID,Hamada Mahmoud^ORCID,Hassnine Alshymaa A,Abd-Elsalam Sherief^ORCID,Abdelghani Ahmed^ORCID,Hassan Mohamed Badr^ORCID,Fattah Shaimaa A

Publisher

Informa UK Limited

Subject

Pharmacology,Internal Medicine

Reference39 articles.

1. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

2. Clinical significance of SNP (rs2596542) in histocompatibility complex class I-related gene A promoter region among hepatitis C virus related hepatocellular carcinoma cases

3. Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection

4. A study of leptin and its gene 2548 G/A Rs7799039 single-nucleotide polymorphisms in Egyptian children: A single-center experience

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurotensin receptor‐1 antagonist SR48692 modulation of high‐fat diet–induced pathogenesis of NAFLD in mice;European Journal of Lipid Science and Technology;2024-04-05

2. Application of noninvasive test (acoustic attenuation imaging and ultrasonic shear wave elastography) to grade nonalcoholic fatty liver disease: An observational study;Medicine;2023-08-11

3. The Role of Hypothalamic Neuropeptides in Regulation of Liver Functions in Health and Disease;Endocrines;2023-06-20

4. Evaluating the Feasibility of Pro-Neurotensin and 25-Hydroxyvitamin D3 as Possible Indicators for Type 2 Diabetes Mellitus and Its Complications;Healthcare;2023-04-11

5. MicroRNAs as Biomarkers and Therapeutic Targets for Nonalcoholic Fatty Liver Disease: A Narrative Review;Clinical Therapeutics;2023-03